LFST LifeStance Health Group, Inc.
Healthcare$7.39-0.94%ClosedMarket Cap: $2.87B
As of 2026-05-25
Valuation
P/E (TTM)
258.16
PEG
2.21
P/B
1.94
P/S
1.92
EV/EBITDA
28.93
DCF Value
$19.23
FCF Yield
6.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
29.9%
Operating Margin
3.0%
Net Margin
1.6%
ROE
1.6%
ROA
1.1%
ROIC
1.6%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $403.5M | 30.4% | $22.4M | $14.2M | $— | — |
| Q4 null | $382.2M | 29.5% | $18.4M | $11.7M | $— | — |
| FY null | $1.42B | 28.5% | $25.7M | $9.7M | $— | — |
| Q3 null | $363.8M | 32.0% | $7.4M | $1.1M | $— | — |
| Q2 null | $345.3M | 27.3% | $-3.0M | $-3.8M | $— | — |
| Q1 null | $333.0M | 33.0% | $1.6M | $709.0K | $— | — |
| Q4 null | $325.5M | 33.6% | $1.1M | $-7.1M | $— | — |
| FY null | $1.25B | 32.2% | $-31.6M | $-57.4M | $— | — |
| Q3 null | $312.7M | 32.1% | $47.0K | $-6.0M | $— | — |
| Q2 null | $312.3M | 31.3% | $-15.9M | $-23.3M | $— | — |
| Q1 null | $300.4M | 31.5% | $-16.8M | $-21.1M | $— | — |
| Q4 2023 | $280.6M | 29.7% | $-32.3M | $-45.0M | $-0.12 | — |